Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156040 | SCV000205753 | likely benign | not specified | 2013-11-08 | criteria provided, single submitter | clinical testing | Gly3325Gly in Exon 51 of USH2A: This variant is not expected to have clinical si gnificance because it does not alter an amino acid, it is not found in a splice consensus sequence, and it was identified in 0.8% (3/394) Chinese chromosomes by the 1000 Genomes Project (dbSNP rs188093326) |
Labcorp Genetics |
RCV000939969 | SCV001085825 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000939969 | SCV001856918 | likely benign | not provided | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453187 | SCV004182622 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453186 | SCV004182623 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888603 | SCV004707897 | likely benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Prevention |
RCV004544446 | SCV004760831 | likely benign | USH2A-related disorder | 2019-12-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |